ATE339496T1 - Modulation von gamma-secretase aktivität - Google Patents

Modulation von gamma-secretase aktivität

Info

Publication number: ATE339496T1
Authority: AT; Austria
Prior art keywords: app; gamma; secretase; assay; modulation
Prior art date: 2000-05-11

Application number

AT01935260T

Other languages

English (en)

Inventor

Barbara Cordell

Jeffrey N Higaki

Mitchell Mutz

Original Assignee

Scios Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-11

Filing date

2001-05-09

Publication date

2006-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22754280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE339496(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-05-09 Application filed by Scios Inc filed Critical Scios Inc

2006-10-15 Application granted granted Critical

2006-10-15 Publication of ATE339496T1 publication Critical patent/ATE339496T1/de

Links

102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title abstract 5
108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title abstract 5
230000000694 effects Effects 0.000 title abstract 2
210000004027 cell Anatomy 0.000 abstract 3
238000003556 assay Methods 0.000 abstract 2
230000035772 mutation Effects 0.000 abstract 2
DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 abstract 1
210000000170 cell membrane Anatomy 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
230000002255 enzymatic effect Effects 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Gastroenterology & Hepatology (AREA)
Neurosurgery (AREA)
General Engineering & Computer Science (AREA)
Toxicology (AREA)
Microbiology (AREA)
Hospice & Palliative Care (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Holo Graphy (AREA)
Investigating Or Analysing Biological Materials (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT01935260T 2000-05-11 2001-05-09 Modulation von gamma-secretase aktivität ATE339496T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US20350600P	2000-05-11	2000-05-11

Publications (1)

Publication Number	Publication Date
ATE339496T1 true ATE339496T1 (de)	2006-10-15

Family

ID=22754280

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01935260T ATE339496T1 (de)	2000-05-11	2001-05-09	Modulation von gamma-secretase aktivität

Country Status (8)

Country	Link
US (2)	US6579689B2 (de)
EP (1)	EP1305406B2 (de)
JP (1)	JP2003532413A (de)
AT (1)	ATE339496T1 (de)
AU (1)	AU2001261368A1 (de)
DE (1)	DE60123074T3 (de)
DK (1)	DK1305406T4 (de)
WO (1)	WO2001085924A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL151828A0 (en) *	2000-04-03	2003-04-10	Bristol Myers Squibb Pharma Co	Proteins having gamma-secretase activity and methods for isolating the same and methods detecting said activity
US20030022251A1 (en) *	2001-07-04	2003-01-30	Boehringer Ingelheim Pharma Kg	Gamma-secretase in vitro screening assay
IL162838A0 (en)	2002-01-04	2005-11-20	Univ Rockefeller	Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
ATE448242T1 (de) *	2002-04-24	2009-11-15	Hiroshi Mori	Gamma-sekretase-inhibitoren
AU2006203819A1 (en) *	2005-01-07	2006-07-13	Roskamp Research Llc	Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
SG10201507362TA (en)	2009-08-05	2015-10-29	Intra Cellular Therapies Inc	Novel Regulatory Proteins And Inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4372888A (en) †	1980-08-26	1983-02-08	The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services	Nondenaturing zwitterionic detergents
CA2191924A1 (en)	1995-12-05	1997-06-06	Kevin Felsenstein	5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
GB9608657D0 (en)	1996-04-26	1996-07-03	Smithkline Beecham Plc	Novel treatment
WO1998015828A1 (en) *	1996-10-07	1998-04-16	Scios Inc.	Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
US6313268B1 (en) †	1998-10-16	2001-11-06	Vivian Y. H. Hook	Secretases related to Alzheimer's dementia
DE19941039A1 (de)	1999-08-28	2001-03-01	Boehringer Ingelheim Pharma	gamma-Sekretase in vitro Testsystem
DE10000161A1 (de)	2000-01-06	2001-07-19	Boehringer Ingelheim Pharma	Verfahren zur Identifikation eines Proteaseinhibitors
IL151828A0 (en)	2000-04-03	2003-04-10	Bristol Myers Squibb Pharma Co	Proteins having gamma-secretase activity and methods for isolating the same and methods detecting said activity

2001
- 2001-05-09 WO PCT/US2001/015089 patent/WO2001085924A2/en not_active Ceased
- 2001-05-09 AU AU2001261368A patent/AU2001261368A1/en not_active Abandoned
- 2001-05-09 JP JP2001582513A patent/JP2003532413A/ja active Pending
- 2001-05-09 US US09/852,914 patent/US6579689B2/en not_active Expired - Lifetime
- 2001-05-09 DE DE60123074.4T patent/DE60123074T3/de not_active Expired - Lifetime
- 2001-05-09 DK DK01935260.8T patent/DK1305406T4/en active
- 2001-05-09 AT AT01935260T patent/ATE339496T1/de not_active IP Right Cessation
- 2001-05-09 EP EP01935260.8A patent/EP1305406B2/de not_active Expired - Lifetime
2003
- 2003-06-17 US US10/464,036 patent/US20030211559A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60123074T2 (de)	2007-03-01
DE60123074D1 (de)	2006-10-26
DK1305406T3 (da)	2007-01-08
US20010055782A1 (en)	2001-12-27
EP1305406A2 (de)	2003-05-02
WO2001085924A3 (en)	2003-02-27
DE60123074T3 (de)	2015-01-29
US20030211559A1 (en)	2003-11-13
WO2001085924A2 (en)	2001-11-15
EP1305406B1 (de)	2006-09-13
DK1305406T4 (en)	2015-02-02
US6579689B2 (en)	2003-06-17
EP1305406B2 (de)	2014-11-12
JP2003532413A (ja)	2003-11-05
AU2001261368A1 (en)	2001-11-20

Legal Events

Date	Code	Title	Description
2007-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DK1210411T3 (da)	2007-02-19	Sammensætninger og fremgangsmåder til forbedret celledyrkning
ATE450635T1 (de)	2009-12-15	Elektrochemische herstellung von peroxo- dischwefelsäure unter einsatz von diamantbeschichteten elektroden
Fox et al.	1997	Identification of potential activators of proteinase‐activated receptor‐2 1
DK1280898T3 (da)	2011-05-16	Modificerede ES-celler og ES-cellespecifikt gen
BR0009362A (pt)	2001-12-26	Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
DE60232234D1 (de)	2009-06-18	Verfahren zur kultivierung von circovirus
IL150168A0 (en)	2002-12-01	Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
DE60141950D1 (de)	2010-06-10	Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
WO2003076932A3 (de)	2004-09-02	Detektion und analyse von protein-interaktionen in vivo
WO2001016285A3 (en)	2001-09-13	Novel proteases and variants thereof
ATE430589T1 (de)	2009-05-15	Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
DE59903410D1 (de)	2002-12-19	Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE69942459D1 (de)	2010-07-15	Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
MXPA03005548A (es)	2004-04-20	Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
ATE474926T1 (de)	2010-08-15	Verwendung von clya hemolysin fur ausscheidung von fusionprotein
ATE307890T1 (de)	2005-11-15	Prohormon-konvertase exprimierende polypeptid- synthese
ATE339496T1 (de)	2006-10-15	Modulation von gamma-secretase aktivität
WO2004011637A3 (en)	2004-04-08	Modified adamts4 molecules and method of use thereof
AU7843101A (en)	2001-12-17	Furin polypeptides with improved characteristics
WO2003012089A3 (en)	2003-05-22	Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
GB9720693D0 (en)	1997-11-26	Assay
WO1999037758A3 (en)	1999-09-30	Expression of proteolytically-sensitive peptides
ATE334592T1 (de)	2006-08-15	Biologische bekämpfung von nematoden
DE69930819D1 (de)	2006-05-24	Nicht-enzymatische methoden zur erzeugung von chemilumineszenz bei acridan-alkenen
WO2003006947A3 (en)	2003-05-08	Cell-screening assay and composition